Integrated BioPharma (INBP) Stock Price, News & Analysis

Company Overview

Integrated BioPharma, Inc. is a health and wellness company focused on the development, manufacturing and distribution of nutritional supplements, vitamins, herbal products and related consumer health offerings. The company serves businesses and consumers seeking products in the dietary supplement and natural health categories.

Its activities have included contract manufacturing and private-label production, as well as the sale and distribution of finished nutritional and wellness products. These capabilities may include formulation, manufacturing, packaging and related services for supplement companies and other customers.

Integrated BioPharma has historically operated in the United States and has served customers through domestic and international distribution channels. Publicly available information about its current operating structure, principal brands and leadership is limited, so additional details cannot be stated reliably.

Key Stats

• Today's Range: $0.18 to $0.18
• 50-Day Range: $0.15 to $0.19
• 52-Week Range: $0.14 to $0.42
• Volume: N/A
• Average Volume: 13,086 shs
• Market Capitalization: $5.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 9/25/2026
• Today: 10/05/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:INBP
• CIK: 1016504
• Web: ir.ibiopharma.com
• Phone: (973) 926-0816
• Fax: 973-926-1735
• Employees: 153
• Year Founded: 1995

Profitability

• EPS (Trailing Twelve Months): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.84 million
• Net Margins: -6.48%
• Pretax Margin: -5.84%
• Return on Equity: -14.78%
• Return on Assets: -11.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.00
• Quick Ratio: 1.42

Sales & Book Value

• Annual Sales: $43.87 million
• Price / Sales: 0.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.57 per share
• Price / Book: 0.32

Miscellaneous

• Outstanding Shares: 30,980,000
• Free Float: 10,098,000
• Market Cap: $5.64 million
• Optionable: Not Optionable
• Beta: 0.50